Litcius/Paper detail

COVID‐19 vaccines do not trigger psoriasis flares in patients with psoriasis treated with apremilast

Alessia Pacifico, Andrea D’Arino, P. D. Pigatto, Piergiorgio Malagoli, Young Dermatologists Italian Network, Giovanni Damiani

2021Clinical and Experimental Dermatology20 citationsDOIOpen Access PDF

Abstract

among patients.These data are in contrast to those of other series, which reported an increase in the percentage of non attendees. 5 We consider that keeping our ED service open not only allowed diagnosis of acute conditions, but also allowed the incidental diagnosis of melanomas or other tumours.This would not have been possible with teleconsultation, as pointed out by other authors. 4 There are some limitations to this study: it was a single-centre study, with data collected retrospectively and was with a previous time series.However, the data reveal changes in healthcare provision and in the usage patterns of healthcare resources as a result of the pandemic.It would be interesting to know why those patients required urgent attention, and if these trends will continue over time or return to pre-pandemic levels.In conclusion, we found that ED consultations remain important during the pandemic period.The observed data are consistent with those reported for the first wave of the virus in other parts of the world.

Topics & Concepts

ApremilastPsoriasisMedicineCoronavirus disease 2019 (COVID-19)DermatologyVaccinationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakImmunologyVirologyPsoriatic arthritisInternal medicineDiseaseInfectious disease (medical specialty)OutbreakPsoriasis: Treatment and PathogenesisSpondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and Therapies